Non-medical influencers dominate Mounjaro (tirzepatide) discussions on X, shaping largely positive public sentiment
Background
The dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro) is FDA-approved for type 2 diabetes but increasingly used off-label for weight loss. Social media platforms like X (formerly Twitter) have become significant venues for public discourse on emerging pharmacotherapies. Understanding the key influencers and conversation dynamics is crucial, as non-expert voices can profoundly shape public awareness and adoption, potentially bypassing evidence-based medical guidance. This study addresses the gap in research examining the specific dynamics of Mounjaro-related discussions on X.
Study Design
Researchers employed a quantitative, exploratory observational design using social network analysis and automated sentiment analysis of publicly available tweets. The dataset comprised 5,566 tweets from 5,641 unique users discussing Mounjaro between January 9 and February 24, 2025. Using NodeXL, betweenness and in-degree centrality measures identified influential users and content sources. Cluster analysis then mapped dominant discussion topics within the network, while sentiment analysis assessed the overall tone of these Mounjaro-related tweets.
Results
The analysis revealed that the most influential users in Mounjaro discussions on X were predominantly non-medical individuals, including public figures and patients sharing personal experiences. Overall public sentiment toward Mounjaro was largely positive, with a significant 62.6% of tweets expressing favorable attitudes. Network clusters identified several dominant discussion topics: weight loss, comparisons with Ozempic and Wegovy, pharmaceutical branding, and diabetes treatment. These findings underscore the substantial role non-expert voices play in shaping online health discourse. > The most influential users discussing Mounjaro on X were predominantly non-medical individuals, including public figures and patients sharing personal experiences, rather than medical professionals.
Key Findings
- Most influential users discussing Mounjaro on X were non-medical individuals, including public figures and patients.
- Overall sentiment towards Mounjaro was largely positive, with 62.6% of tweets expressing favorable attitudes.
- Key discussion clusters included weight loss, comparisons with Ozempic/Wegovy, pharmaceutical branding, and diabetes treatment.
Why It Matters
This study highlights a critical challenge for evidence-based health communication in the digital age: non-expert voices significantly influence public perception of new pharmacotherapies like Mounjaro. For individuals considering tirzepatide for weight loss or diabetes, this means much of the readily available information online may come from anecdotal experiences rather than clinical data. Clinicians and public health communicators must develop targeted strategies to ensure accurate, evidence-based information reaches patients amidst pervasive social media influence. Users should exercise caution and verify information from non-medical sources, prioritizing discussions with healthcare professionals for personalized medical advice.
mounjaro
tirzepatide
social-media
health-communication
weight-loss
type-2-diabetes